Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Insulins | Research article

Insulin resistance and reduced cardiac autonomic function in older adults: the Atherosclerosis Risk in Communities study

Authors: Anna K. Poon, Eric A. Whitsel, Gerardo Heiss, Elsayed Z. Soliman, Lynne E. Wagenknecht, Takeki Suzuki, Laura Loehr

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Prior studies have shown insulin resistance is associated with reduced cardiac autonomic function measured at rest, but few studies have determined whether insulin resistance is associated with reduced cardiac autonomic function measured during daily activities.

Methods

We examined older adults without diabetes with 48-h ambulatory electrocardiography (n = 759) in an ancillary study of the Atherosclerosis Risk in Communities Study. Insulin resistance, the exposure, was defined by quartiles for three indexes: 1) the homeostatic model assessment of insulin resistance (HOMA-IR), 2) the triglyceride and glucose index (TyG), and 3) the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C). Low heart rate variability, the outcome, was defined by <25th percentile for four measures: 1) standard deviation of normal-to-normal R-R intervals (SDNN), a measure of total variability; 2) root mean square of successive differences in normal-to-normal R-R intervals (RMSSD), a measure of vagal activity; 3) low frequency spectral component (LF), a measure of sympathetic and vagal activity; and 4) high frequency spectral component (HF), a measure of vagal activity. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals weighted for sampling/non-response, adjusted for age at ancillary visit, sex, and race/study-site. Insulin resistance quartiles 4, 3, and 2 were compared to quartile 1; high indexes refer to quartile 4 versus quartile 1.

Results

The average age was 78 years, 66% (n = 497) were women, and 58% (n = 438) were African American. Estimates of association were not robust at all levels of HOMA-IR, TyG, and TG/HDL-C, but suggest that high indexes were associated consistently with indicators of vagal activity. High HOMA-IR, high TyG, and high TG/HDL-C were consistently associated with low RMSSD (OR: 1.68 (1.00, 2.81), OR: 2.03 (1.21, 3.39), and OR: 1.73 (1.01, 2.91), respectively). High HOMA-IR, high TyG, and high TG/HDL-C were consistently associated with low HF (OR: 1.90 (1.14, 3.18), OR: 1.98 (1.21, 3.25), and OR: 1.76 (1.07, 2.90), respectively).

Conclusions

In older adults without diabetes, insulin resistance was associated with reduced cardiac autonomic function – specifically and consistently for indicators of vagal activity – measured during daily activities. Primary prevention of insulin resistance may reduce the related risk of cardiac autonomic dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li C, Ford E, McGuire L, Mokdad A, Little R, Reaven G. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care. 2006;29:2396–402.CrossRef Li C, Ford E, McGuire L, Mokdad A, Little R, Reaven G. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care. 2006;29:2396–402.CrossRef
2.
go back to reference Ginsberg H. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453–8.CrossRef Ginsberg H. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453–8.CrossRef
3.
go back to reference Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32:1754–9.CrossRef Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32:1754–9.CrossRef
4.
go back to reference Liao D, Carnethon M, Evans G, Cascio W, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes. 2002;51:3524–31.CrossRef Liao D, Carnethon M, Evans G, Cascio W, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes. 2002;51:3524–31.CrossRef
5.
go back to reference Gerritsen J, Dekker J, TenVoorde B, Kostense P, Heine R, Bouter L, Heethaar R, Stehouwer C. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn study. Diabetes Care. 2001;24:1793–8.CrossRef Gerritsen J, Dekker J, TenVoorde B, Kostense P, Heine R, Bouter L, Heethaar R, Stehouwer C. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn study. Diabetes Care. 2001;24:1793–8.CrossRef
6.
go back to reference Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly S, de Las FL, He S, Okunade A, Patterson B, Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591–601.CrossRef Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly S, de Las FL, He S, Okunade A, Patterson B, Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591–601.CrossRef
7.
go back to reference Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374–81.CrossRef Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374–81.CrossRef
8.
go back to reference Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043–65. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043–65.
9.
go back to reference Hillebrand S, Gast K, de Mutsert R, Swenne C, Jukema J, Middeldorp S, Rosendaal F, Dekkers O. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15:742–9.CrossRef Hillebrand S, Gast K, de Mutsert R, Swenne C, Jukema J, Middeldorp S, Rosendaal F, Dekkers O. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15:742–9.CrossRef
10.
go back to reference Singh J, Larson M, O’Donnell C, Wilson P, Tsuji H, Lloyd-Jones D, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86:309–12.CrossRef Singh J, Larson M, O’Donnell C, Wilson P, Tsuji H, Lloyd-Jones D, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86:309–12.CrossRef
11.
go back to reference Schroeder E, Chambless L, Liao D, Prineas R, Evans G, Rosamond W, Heiss G. Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2005;28:668–74.CrossRef Schroeder E, Chambless L, Liao D, Prineas R, Evans G, Rosamond W, Heiss G. Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2005;28:668–74.CrossRef
12.
go back to reference Liao D, Cai J, Brancati F, Folsom A, Barnes R, Tyroler H, Heiss G. Association of vagal tone with serum insulin, glucose, and diabetes mellitus--the ARIC study. Diabetes Res Clin Pract. 1995;30:211–21.CrossRef Liao D, Cai J, Brancati F, Folsom A, Barnes R, Tyroler H, Heiss G. Association of vagal tone with serum insulin, glucose, and diabetes mellitus--the ARIC study. Diabetes Res Clin Pract. 1995;30:211–21.CrossRef
13.
go back to reference DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys. 1979;237:E214–23. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys. 1979;237:E214–23.
14.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.CrossRef Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.CrossRef
15.
go back to reference Guerrero-Romero F, Simental-Mendia L, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala M, Hernandez-Gonzalez S, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.CrossRef Guerrero-Romero F, Simental-Mendia L, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala M, Hernandez-Gonzalez S, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.CrossRef
16.
go back to reference McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss R. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.CrossRef McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss R. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.CrossRef
17.
go back to reference Loehr LR, Soliman EZ, Poon AK, Couper D, Chen LY, Mosley TH, Wagenknecht LE, Whitsel EA, Alonso A, Wruck L, Heiss G. The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to whites: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2019;216:1–8.CrossRef Loehr LR, Soliman EZ, Poon AK, Couper D, Chen LY, Mosley TH, Wagenknecht LE, Whitsel EA, Alonso A, Wruck L, Heiss G. The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to whites: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2019;216:1–8.CrossRef
18.
go back to reference The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129:687–702. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129:687–702.
20.
go back to reference Poon AK, Meyer M, Reaven G, Knowles J, Selvin E, Pankow J, Couper D, Loehr L, Heiss G. Short-term repeatability of insulin resistance indexes in older adults: the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2018;103:2175–81.CrossRef Poon AK, Meyer M, Reaven G, Knowles J, Selvin E, Pankow J, Couper D, Loehr L, Heiss G. Short-term repeatability of insulin resistance indexes in older adults: the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2018;103:2175–81.CrossRef
22.
go back to reference Rodriguez-Colon SM, Li X, Shaffer ML, He F, Bixler EO, Vgontzas AN, Cai J, Liao D. Insulin resistance and circadian rhythm of cardiac autonomic modulation. Cardiovasc Diabetol. 2010;9:85.CrossRef Rodriguez-Colon SM, Li X, Shaffer ML, He F, Bixler EO, Vgontzas AN, Cai J, Liao D. Insulin resistance and circadian rhythm of cardiac autonomic modulation. Cardiovasc Diabetol. 2010;9:85.CrossRef
23.
go back to reference Saito I, Hitsumoto S, Maruyama K, Nishida W, Eguchi E, Kato T, Kawamura R, Takata Y, Onuma H, Osawa H, Tanigawa T. Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: the Toon health study. J Epidemiol. 2015;25:583–91.CrossRef Saito I, Hitsumoto S, Maruyama K, Nishida W, Eguchi E, Kato T, Kawamura R, Takata Y, Onuma H, Osawa H, Tanigawa T. Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: the Toon health study. J Epidemiol. 2015;25:583–91.CrossRef
24.
go back to reference Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258.CrossRef Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258.CrossRef
25.
26.
go back to reference Valensi P, Extramiana F, Lange C, Cailleau M, Haggui A, Maison Blanche P, Tichet J, Balkau B. Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diab Med. 2011;28:440–9.CrossRef Valensi P, Extramiana F, Lange C, Cailleau M, Haggui A, Maison Blanche P, Tichet J, Balkau B. Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study. Diab Med. 2011;28:440–9.CrossRef
27.
go back to reference Quilliot D, Fluckiger L, Zannad F, Drouin P, Ziegler O. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res. 2001;11:79–86.CrossRef Quilliot D, Fluckiger L, Zannad F, Drouin P, Ziegler O. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res. 2001;11:79–86.CrossRef
28.
go back to reference Quilliot D, Zannad F, Ziegler O. Impaired response of cardiac autonomic nervous system to glucose load in severe obesity. Metab Clin Exp. 2005;54:966–74.CrossRef Quilliot D, Zannad F, Ziegler O. Impaired response of cardiac autonomic nervous system to glucose load in severe obesity. Metab Clin Exp. 2005;54:966–74.CrossRef
29.
go back to reference Paolisso G, Manzella D, Rizzo MR, Barbieri M, Varricchio G, Gambardella A, Varricchio M. Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states. Clin Sci (London). 2000;98:129–36.CrossRef Paolisso G, Manzella D, Rizzo MR, Barbieri M, Varricchio G, Gambardella A, Varricchio M. Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states. Clin Sci (London). 2000;98:129–36.CrossRef
30.
go back to reference Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, Baldi S, Carpeggiani C, Ferrannini E. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab. 1998;83:2084–90.PubMed Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, Baldi S, Carpeggiani C, Ferrannini E. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab. 1998;83:2084–90.PubMed
31.
go back to reference Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI, Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes. 1999;48:1295–9.CrossRef Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI, Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes. 1999;48:1295–9.CrossRef
32.
go back to reference Poon AK, Meyer ML, Tanaka H, Selvin E, Pankow J, Zeng D, Loehr L, Knowles JW, Rosamond W, Heiss G. Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the atherosclerosis risk in communities study. Cardiovasc Diabetol. 2020;19:11.CrossRef Poon AK, Meyer ML, Tanaka H, Selvin E, Pankow J, Zeng D, Loehr L, Knowles JW, Rosamond W, Heiss G. Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the atherosclerosis risk in communities study. Cardiovasc Diabetol. 2020;19:11.CrossRef
33.
go back to reference Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.CrossRef Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.CrossRef
34.
go back to reference Stevens MJ. Cardiovascular autonomic neuropathy. In: Veves A, Malik RA, editors. Diabetic neuropathy: clinical management. 2nd ed. Totowa: Humana Press; 2007. p. 389–92.CrossRef Stevens MJ. Cardiovascular autonomic neuropathy. In: Veves A, Malik RA, editors. Diabetic neuropathy: clinical management. 2nd ed. Totowa: Humana Press; 2007. p. 389–92.CrossRef
Metadata
Title
Insulin resistance and reduced cardiac autonomic function in older adults: the Atherosclerosis Risk in Communities study
Authors
Anna K. Poon
Eric A. Whitsel
Gerardo Heiss
Elsayed Z. Soliman
Lynne E. Wagenknecht
Takeki Suzuki
Laura Loehr
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01496-z

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue